Subject: Compassionate use programs
From: "BEATRICE - ELENA LASCU" <[email-masked]>
To: "BEATRICE - ELENA LASCU" <[email-masked]>
Date: Thu, 16 May 2024 15:58:40 +0300

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu 
saatja korral palume linke ja faile mitte avada.

Dear Sir/ Madam,

could you help me with an explanation of how Article 83 of Regulation (EC) 
No 726/2004 applies in your country? Could you help me with a legislative 
article?
In addition, is there a distinction made between CUP (compassionate use 
program), NPP (name patient prescription), or EAP (expanded access program)?

Thank you in advance for your help!

Beatrice Lascu, RPh